Literature DB >> 23484455

The relationship of patient-reported joints with active synovitis detected by power Doppler ultrasonography in rheumatoid arthritis.

Peter P Cheung1, Laure Gossec, Adeline Ruyssen-Witrand, Catherine Le Bourlout, Maryse Mézières, Maxime Dougados.   

Abstract

OBJECTIVES: This paper aims to evaluate the relationship of patient-reported tender and swollen joints with active inflammation as detected by power Doppler (PDUS) and whether this relationship is affected by significant joint damage.
METHODS: Fifty rheumatoid arthritis patients self-assessed 28 tender and swollen joints and were followed by PDUS assessment. Relationship of tender and swollen joints with active synovitis (PDUS 'gold standard') was assessed at the joint level by: a) percentage agreement at each PDUS semiquantitative grade (grade 1 to 3), b) positive likelihood ratio (LR) of agreement with PDUS, and c) LR of agreement with PDUS according to radiographic damage (significant erosive disease vs. non-erosive disease). Correlation of tender and swollen joint counts with disease activity markers was analysed by Spearman's. Sensitivity analyses examined the influence of disease activity or global pain on level of agreement at the joint level.
RESULTS: Of joints with significant active inflammation (e.g. grade 3 PDUS), patients identified 75% as tender and 63% as swollen. Swollen joints showed strong association at the joint level with active synovitis when there was no significant radiographic damage (LR 2.54, 95%CI 1.93-3.34), but with no significant radiographic damage (LR 1.32, 95%CI 0.75-2.32). Swollen joint counts were statistically correlated with PDUS-DAS28 and CRP, but not PDUS score. Sensitivity analysis showed better agreement of tender and swollen joints with active synovitis when DAS28 was ≤ 3.2 and when patient global pain was <50mm on visual analogue scale.
CONCLUSIONS: The relationship between patient-reported joints and active synovitis is stronger in the setting of low disease activity without erosive disease, affected also by degree of reported global pain. Further longitudinal studies of patient-reported joints are needed.

Entities:  

Mesh:

Year:  2013        PMID: 23484455

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  2 in total

1.  Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis.

Authors:  Generoso Guerra Bautista; Ricardo Machado Xavier; Maria de la Vega; J Abraham Simón-Campos; Gastón Solano; Ronald D Pedersen; Bonnie Vlahos; Cecilia Borlenghi
Journal:  Open Access Rheumatol       Date:  2019-12-12

2.  Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

Authors:  Maxime Dougados; Martin Soubrier; Elodie Perrodeau; Laure Gossec; Françoise Fayet; Mélanie Gilson; Marie-Hélène Cerato; Sophie Pouplin; René-Marc Flipo; Laurent Chabrefy; Gael Mouterde; Liana Euller-Ziegler; Thierry Schaeverbeke; Bruno Fautrel; Alain Saraux; Isabelle Chary-Valckenaere; Gérard Chales; Emmanuelle Dernis; Pascal Richette; Xavier Mariette; Francis Berenbaum; Jean Sibilia; Philippe Ravaud
Journal:  Ann Rheum Dis       Date:  2014-05-28       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.